24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2026
2026 VC Survey
Boarding Pass
CTalk
BiblioTech
Corporate
Appointments
Tech Gateways
HR - The Next Leap
Ctech Testimonials
Projects
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
pharmaceutical
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
Projects
ABOUT
teram of use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
17:30
"We're nearing the end of the traditional, one-size-fits-all classroom": Israeli tech leaders predict what technology will leave behind
17:18
“AI overshadows everything”: BlackRock and Blackstone ask whether the profits will follow
16:57
Bank of Israel governor warns next government must curb defense spending and invest in growth
16:00
After six years in stealth, Hemispheric emerges with $52 million to build a foundation AI model for the human brain
More stories
Buzz
Most popular
Daily
Weekly
1
Qatar blocks Volkswagen's Iron Dome deal with Rafael as German plant faces closure
2
Cribl acquires Israeli cyber startup CardinalOps for around $100 million
3
EU backs Israeli antibiotic developer with €8 million grant to combat deadly superbugs
4
Two Israeli quantum startups target Wall Street in multibillion-dollar SPAC deals
5
Israeli startups Kela and eyesAtop to power IDF's autonomous attack drones
More news
pharmaceutical
4 stories about pharmaceutical
Life Sciences Venture Fund aMoon Closes Second Fund at $660 Million
06.03.19
|
Hagar Ravet
The second fund will focus on mid to late-stage health companies in the domains of pharma, digital health, and medical technology
Regulation Hinders Innovative Drug Development in Israel, Executives Say
04.09.17
|
Naomi Zoreff
Despite Israel's advanced medical infrastructure, excessive red tape steers pharmaceutical companies away
Developer Of Anti-Rabies Drug Jumps on FDA Approval
27.08.17
|
Dror Reich
The plasma-derived drug is used together with the rabies vaccine to treat unvaccinated persons exposed to the virus
U.S. Congress to Investigate Rising Multiple Sclerosis Drug Prices
21.08.17
|
Dror Reich
Two Congressmen are looking into the rising MS drug prices of seven pharmaceutical companies